XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.2
Supplemental Financial Information - Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Other Balance Sheet Details [Abstract]    
Sales rebates and reserves $ 175.6 $ 144.2
Accrued employee related costs 84.6 107.5
Accrued development costs (including unpaid development milestones) 61.0 50.8
Current branded prescription drug fee 38.0 49.2
Current income taxes payable 25.7 9.9
Accounts payable and other accrued liabilities 104.6 100.0
Total accounts payable and accrued liabilities $ 489.5 $ 461.6